Patents-Review.com
ClassID:

21016 ⎘

A61K38/395 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Alveolar surfactant peptides; Pulmonary surfactant peptides

Recent Application in this class:
#1
20260027198
2026-01-29

VIRUS POLYPEPTIDE-PROTEIN SUBUNIT COMBINATION VACCINE BASED ON DNA NANOTECHNOLOGY, AND PREPARATION METHOD THEREFOR AND USE THEREOF

 #2
20250262150
2025-08-21

Surfactant Formulations for Inhalation

 #3
20250222075
2025-07-10

NOVEL APPLICATION OF HUMAN AIRWAY SURFACTANT, BPIFA1, AS PROPHYLACTIC ANTIVIRAL AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV)

 #4
20250152676
2025-05-15

METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE

 #5
20250082783
2025-03-13

COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF GENETIC DISEASE

 #6
20240398905
2024-12-05

COMPOSITIONS AND METHOD FOR ADMINISTERING PPARgamma AGONISTS, SURFACTANT PEPTIDES AND PHOSOPHOLIPIDS

 #7
20240269242
2024-08-15

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING LUNG DISEASE

 #8
20240091319
2024-03-21

DUAL-ADMINISTRATION METHODS FOR TREATING RESPIRATORY DISTRESS

 #9
20230233694
2023-07-27

ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER

 #10
20230181697
2023-06-15

Use of Surfactant Protein D to Treat Viral Infections

 #11
20230108852
2023-04-06

CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D

 #12
20230040391
2023-02-09

METHOD OF PROGNOSIS OF BRONCHOPULMONARY DYSPLASIA IN PREMATURE INFANTS

 #13
20220047681
2022-02-17

Compositions and methods for administering PPARγ agonists, surfactant peptides and phospholipids

 #14
20210330753
2021-10-28

METHODS OF TREATING COVID-19 MEDIATED LUNG DAMAGE USING SURFACTANTS AND NATURAL ANTIBODIES

 #15
20210220445
2021-07-22

THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID FOR THE PROPHYLAXIS OF BPD

 #16
20210169794
2021-06-10

Surfactant Formulations for Inhalation

 #17
20210121536
2021-04-29

METHODS AND COMPOSITIONS COMPRISING SURFACTANT PROTEIN D (SP-D)

 #18
20200390855
2020-12-17

COMPOSITIONS, ARTICLES OF MANUFACTURE AND METHODS FOR TREATING CANCER

 #19
20200297812
2020-09-24

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #20
20200297811
2020-09-24

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #21
20200297810
2020-09-24

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #22
20200297809
2020-09-24

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #23
20200297808
2020-09-24

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #24
20200297807
2020-09-24

Compositions and methods for treating cancer

 #25
20200297806
2020-09-24

Compositions and methods for treating cancer

 #26
20200297805
2020-09-24

Compositions and methods for treating cancer

 #27
20200297804
2020-09-24

Compositions and methods for treating cancer

 #28
20200297803
2020-09-24

Compositions and methods for treating cancer

 #29
20200297802
2020-09-24

Compositions and methods for treating cancer

 #30
20200289626
2020-09-17

Compositions and method for administering PPARgamma agonists, surfactant peptides and phosopholipids

 #31
20200276267
2020-09-03

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #32
20200268846
2020-08-27

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #33
20200268845
2020-08-27

Compositions and methods for treating cancer

 #34
20200268844
2020-08-27

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #35
20200268843
2020-08-27

Compositions and methods for treating cancer

 #36
20200268842
2020-08-27

Compositions and methods for treating cancer

 #37
20200268841
2020-08-27

Compositions and methods for treating cancer

 #38
20200268840
2020-08-27

Compositions and methods for treating cancer

 #39
20200261547
2020-08-20

CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D

 #40
20200206319
2020-07-02

METHOD FOR PREVENTING OR TREATING SEXUALLY TRANSMITTED INFECTIONS

 #41
20200197496
2020-06-25

Particles comprising surfactant protein B and one or more lipids

 #42
20200046808
2020-02-13

DILUTE SURFACTANT OR ISOLATED SURFACTANT PROTEIN SOLUTION FOR THE REDUCTION OF SURFACE TENSION IN THE LUNG

 #43
20190321452
2019-10-24

THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID FOR THE PROPHYLAXIS OF BPD

 #44
20190117741
2019-04-25

Compositions and methods for treating and preventing lung disease

 #45
20190060416
2019-02-28

Surfactant protein D for the treatment of disorders associated with lung injury

 #46
20190030175
2019-01-31

Antibody-SN-38 immunoconjugates with a CL2A linker

 #47
20180360749
2018-12-20

METHODS AND COMPOSITIONS FOR DELIVERY OF MEDICAMENTS TO THE LUNGS

 #48
20180264047
2018-09-20

CELL CULTURE SUPERNATANT FLUID DERIVED FROM LUNG TISSUE

 #49
20180161440
2018-06-14

Antibody-SN-38 immunoconjugates with a CL2A linker

 #50
20180161404
2018-06-14

Controlled release system for pulmonary delivery of surfactant protein D

 #51
20180147262
2018-05-31

NOVEL SKIN MEDICAL AND COSMETIC CARE PRODUCT

 #52
20180140670
2018-05-24

Compositions, articles of manufacture and methods for treating cancer

 #53
20180140660
2018-05-24

Compositions and methods for treating cancer

 #54
20180055914
2018-03-01

Stable pharmaceutical formulation comprising a reconstituted pulmonary surfactant composition

 #55
20170136099
2017-05-18

Surfactant protein D for the treatment of disorders associated with lung injury

 #56
20170128536
2017-05-11

Pharmaceutical compositions and their use for the treatment of autoimmune disorders

 #57
20170056481
2017-03-02

Treating infection

 #58
20160375106
2016-12-29

Dilute surfactant or isolated surfactant protein solution for the reduction of surface tension in the lung

 #59
20160303253
2016-10-20

Antibody-SN-38 immunoconjugates with a CL2A linker

 #60
20160256562
2016-09-08

Antibody-SN-38 immunoconjugates with a CL2A linker

 #61
20160115537
2016-04-28

Prognosis of chronic obstructive pulmonary disease (COPD) and treament for COPD

 #62
20150343027
2015-12-03

Hypotonic aqueous composition with reduced chloride content, with or without phospholipids

 #63
20150306243
2015-10-29

Antibody-SN-38 immunoconjugates with a CL2A linker

 #64
20150297524
2015-10-22

Lyophilization of synthetic liposomal pulmonary surfactant

 #65
20150182599
2015-07-02

Surfactant protein D for the treatment of disorders associated with lung injury

 #66
20140378383
2014-12-25

METHODS AND COMPOSITIONS FOR DELIVERY OF MEDICAMENTS TO THE LUNGS

 #67
20140243272
2014-08-28

Compound and method for treatment of Alzheimer's disease

 #68
20140227180
2014-08-14

Antibody-SN-38 immunoconjugates with a CL2A linker

 #69
20140142021
2014-05-22

Reconstituted pulmonary surfactants

 #70
20140135268
2014-05-15

Surfactant protein D for the treatment of disorders associated with lung injury

 #71
20140088026
2014-03-27

Lyophilization of synthetic liposomal pulmonary surfactant

 #72
20140088025
2014-03-27

Lyophilization of synthetic liposomal pulmonary surfactant

 #73
20130184202
2013-07-18

Peptide Inhibitors and Methods of Use Thereof

 #74
20130183304
2013-07-18

NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES

 #75
20130079275
2013-03-28

Reconstituted surfactants having improved properties

 #76
20120258070
2012-10-11

Methods and compositions for promoting organ development

 #77
20120220531
2012-08-30

SURFACTANT PROTEIN D FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH LUNG INJURY

 #78
20120148554
2012-06-14

Therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes

 #79
20120122794
2012-05-17

Methods for treatment of Alzheimer's disease

 #80
20120017896
2012-01-26

Method of administration of a pulmonary surfactant

 #81
20110189104
2011-08-04

Surfactant protein D for the treatment of disorders associated with lung injury

 #82
20110070216
2011-03-24

THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND ANTIOXIDANT ENZYMES

 #83
20110003733
2011-01-06

Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)

 #84
20100284969
2010-11-11

Methods and Compositions for Delivery of Medicaments to the Lungs

 #85
20100273712
2010-10-28

SURFACTANT USAGE IN LUNG TRANSPLANTATION AND METHODS THEREOF

 #86
20100035808
2010-02-11

Methods for promoting organ development

 #87
20100004173
2010-01-07

Reconstituted surfactants having improved properties

 #88
20090258823
2009-10-15

COMPOSITION AND METHODS FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL INFECTIONS

 #89
20090110756
2009-04-30

Methods and compositions related to PLUNC surfactant polypeptides

 #90
20080305180
2008-12-11

Method of administration of a pulmonary surfactant

 #91
20080255043
2008-10-16

Human lung surfactant protein, SP-D, modulates eosinophil activation and survival and enhances phagocytosis of apoptotic bosinophils

 #92
20080242615
2008-10-02

SURFACTANT PROTEIN-D FOR PREVENTION AND TREATMENT OF LUNG INFECTIONS AND SEPSIS

 #93
20080064633
2008-03-13

Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions

 #94
20070244045
2007-10-18

Treatment of Acute Respiratory Distress Syndrome

 #95
20070129297
2007-06-07

Treatment and prevention of asthma

 #96
20060286038
2006-12-21

Pulmonary surfactant formulations

 #97
20060229242
2006-10-12

Composition comprising a pulmonary surfactant and a pde2 inhibitor

 #98
20060194728
2006-08-31

Surfactant treatment regimen